NCT06389110View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.

PHASE3RecruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

October 30, 2027

Study Completion Date

October 30, 2027

Conditions
MyopiaMyopia, Progressive
Interventions
DRUG

Alleance®

Atropine sulfate 0.01%, ophthalmic solution.

DRUG

Placebo

Ophthalmic solution.

Trial Locations (1)

14090

RECRUITING

Innovación Y Desarrollo En Ciencias de La Salud S de Rl de Cv, Mexico City

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY